5th International Conference on Lymphocyte Engineering
On behalf of the Scientific Committee of the 5th International Conference on Lymphocyte Engineering, we would like to inform you that EFI members are invited to register by the Early Bird deadline (30th October) and save up to €230.
You are cordially invited to attend the ICLE congress unfolding from 20th to 22nd February 2025 in Munich, Germany.
In recent years, the landscape of lymphocyte engineering has undergone remarkable transformations in the battle against cancer, autoimmune disorders, infectious diseases, and primary immune deficiencies. The integration of gene therapy, cell therapy, and immune therapy has propelled this dynamic field, embracing state-of-the-art technologies such as advanced vectorology, genome editing, in-vivo engineering, and precision protein design. Noteworthy clinical breakthroughs, the approval of innovative therapies by regulatory bodies, and a surge in research activities underscore the pivotal role of lymphocyte engineering in shaping the forefront of medical progress.
As we embark on ICLE 2025, get ready for an exhilarating experience with three extraordinary speakers leading the charge. We are thrilled to announce the keynote speaker, Dr. Drew Weissman, 2023 Nobel Laureate for Medicine and Physiology, for the co-invention of the modified mRNA technology. Joining him are the visionaries Dr. Carl June and Dr. Michel Sadelain, the pioneers of CAR T clinical translation.
Acknowledging the formidable challenges ahead, ICLE 2025 is strategically crafted to facilitate the dynamic exchange of knowledge, ideas, and data, foster collaborations, and collectively address shared challenges. We aim to propel the translation of groundbreaking discoveries into clinical applications, marking a crucial stride forward in the evolution of lymphocyte engineering.
ICLE stands as the pinnacle of scientific convergence, where the global scientific community gathers for three transformative days of active learning, discussions of real-world case studies, and networking opportunities with like-minded peers. It’s not just an event on the calendar; it’s a cause and a mission. A cause dedicated to building the future of medicine collectively, drawing inspiration and knowledge from each other through collaboration and partnership.